Increase in mouse brain dopamine content by baclofen: Effects of apomorphine and neuroleptics
- 1 January 1977
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 52 (3), 217-221
- https://doi.org/10.1007/bf00426702
Abstract
Baclofen, like γ-butyrolactone, causes a dose-dependent increase in the concentration of dopamine in the mouse brain without affecting the content of norepinephrine. This increase is antagonized by apomorphine. Haloperidol but not pimozide counteracts this effect of apomorphine and dose-dependently enhances the increase in brain dopamine produced by baclofen. The results suggest that baclofen reduces impulse flow in dopaminergic neurons in a manner similar to that produced by γ-butyrolactone.Keywords
This publication has 15 references indexed in Scilit:
- Synaptic mechanisms in the substantia nigraJournal of Pharmacy and Pharmacology, 1976
- Differential actions of dopamine agonists and antagonists on the ?-butyrolactone-induced increase in mouse brain dopaminePsychopharmacology, 1976
- Inhibition by γ‐hydroxybutyrate of chlorpromazine‐induced increase in homovanillic acidBritish Journal of Pharmacology, 1973
- Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activityJournal of Pharmacy and Pharmacology, 1972
- The influence of 1-hydroxy-3-amino-pyrrolidinone-2 (HA-966) on dopamine metabolism in the rat corpus striatumEuropean Journal of Pharmacology, 1971
- Receptor activity and turnover of dopamine and noradrenaline after neurolepticsEuropean Journal of Pharmacology, 1970
- A new agent for the control of spasticityJournal of Neurology, Neurosurgery & Psychiatry, 1970
- Evidence for dopamine receptor stimulation by apomorphineJournal of Pharmacy and Pharmacology, 1967
- Selective increase of brain dopamine induced by gamma-hydroxybutyrateLife Sciences, 1966
- A sensitive method for spectrophotofluorometric assay of catecholaminesInternational Journal of Neuropharmacology, 1964